Headline News

 

Kite presents data at EHA 2024 showing positive outcomes and advances in CAR T-cell therapy

Posted on May 19, 2024

Roche recievs FDA approval for HPV self-collection solutions to help eliminate cervical cancer

Posted on May 19, 2024

Roche announces positive phase Ib results for dual GLP-1/GIP receptor agonist CT-388 in people with obesity

Posted on May 19, 2024

GSK announces that they are to become a founding partner of Fleming Initiative to fight antimicrobial resistance

Posted on May 19, 2024

Bristol Myers Squibb’s Breyanzi recieves approval by the U.S. FDA for relapsed or refractory follicular lymphoma

Posted on May 19, 2024

New Sotyktu data shows durable response rates and safety in moderate-to-severe plaque psoriasis

Posted on May 19, 2024

Lillys announcement on Mounjaro and Zepbound Compounding Litigation

Posted on May 19, 2024

Lillys’ Insulin Efsitora Alfa delivers A1C reduction and safety profile consistent with daily Insulin

Posted on May 19, 2024

SUPERNOVA Phase III trial meets primary endpoints in preventing COVID-19 in immunocompromised patient population

Posted on May 19, 2024

AbbVie and Gilgamesh pharmaceuticals announce their collaboration to develop next-generation therapies for psychiatric disorders

Posted on May 13, 2024

AC Immune and Takeda sign license agreement for active immunotherapy targeting amyloid beta for Alzheimer’s Disease

Posted on May 13, 2024

Kite and Arcellx announce advances in anito-cel multiple myeloma program

Posted on May 13, 2024

U.S. FDA announces acceptance of Bristol Myers Squibb’s application for subcutaneous nivolumab

Posted on May 13, 2024

EMA validates Opdivo plus Yervoy for first-line treatment of adult patients with Microsatellite

Posted on May 13, 2024

Bristol Myers Squibb’s update on Phase 3 CheckMate -73L Trial

Posted on May 13, 2024